These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32344148)
1. The impact of anticancer drugs on the ocular surface. Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K Ocul Surf; 2020 Jul; 18(3):403-417. PubMed ID: 32344148 [TBL] [Abstract][Full Text] [Related]
2. Ocular surface complications of local anticancer drugs for treatment of ocular tumors. Moon J; Choi SH; Lee MJ; Jo DH; Park UC; Yoon SO; Woo SJ; Oh JY Ocul Surf; 2021 Jan; 19():16-30. PubMed ID: 33238207 [TBL] [Abstract][Full Text] [Related]
3. Ocular Surface Side Effects of Novel Anticancer Drugs. Vitiello L; Lixi F; Coco G; Giannaccare G Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254833 [TBL] [Abstract][Full Text] [Related]
4. Ocular surface toxicities associated with modern anticancer therapies. Boucher R; Haigh O; Barreau E; Champiat S; Lambotte O; Adam C; Labetoulle M; Rousseau A Surv Ophthalmol; 2024; 69(2):198-210. PubMed ID: 37806566 [TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity and cancer chemotherapy. A review. al-Tweigeri T; Nabholtz JM; Mackey JR Cancer; 1996 Oct; 78(7):1359-73. PubMed ID: 8839540 [TBL] [Abstract][Full Text] [Related]
6. [Ocular disorders of anticancer drugs--ocular side effects]. Kashiwagi H Gan To Kagaku Ryoho; 2010 Sep; 37(9):1639-44. PubMed ID: 20841924 [TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
9. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders. Agustoni F; Platania M; Vitali M; Zilembo N; Haspinger E; Sinno V; Gallucci R; de Braud F; Garassino MC Cancer Treat Rev; 2014 Feb; 40(1):197-203. PubMed ID: 23850197 [TBL] [Abstract][Full Text] [Related]
10. Ocular adverse effects of anti-cancer chemotherapy. Stoicescu EA; Iancu RC; Popa Cherecheanu A; Iancu G J Med Life; 2023 Jun; 16(6):818-821. PubMed ID: 37675170 [TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
12. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
16. Label-Free Bioelectrochemical Methods for Evaluation of Anticancer Drug Effects at a Molecular Level. Tadini-Buoninsegni F; Palchetti I Sensors (Basel); 2020 Mar; 20(7):. PubMed ID: 32218227 [TBL] [Abstract][Full Text] [Related]
17. Ocular side effects of cancer chemotherapy. Vizel M; Oster MW Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524 [TBL] [Abstract][Full Text] [Related]
18. Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles. Xu R; Wang Q J Biomed Inform; 2015 Jun; 55():64-72. PubMed ID: 25817969 [TBL] [Abstract][Full Text] [Related]
19. Metastatic tumors of the orbit and ocular adnexa. Ahmad SM; Esmaeli B Curr Opin Ophthalmol; 2007 Sep; 18(5):405-13. PubMed ID: 17700235 [TBL] [Abstract][Full Text] [Related]